IL6 and chronic obstructive pulmonary disease: However, their application in pathological conditions such as COPD must be approached cautiously, as certain nanoparticles can trigger cytotoxicity and stimulate pro-inflammatory cytokines like IL-1β, IL-6, and IL-18.